Press-release for stocks for biib

Prices are updated after-hours

| -1.12% | O: 1.96% H: 1.5% C: 1.28%
aduhelm alzheimer disease phase 3 merge alzheimer’s alzheimer's disease alzheimer's

| -1.12% | O: 1.96% H: 1.5% C: 1.28%
aduhelm alzheimer disease phase 3 alzheimer’s alzheimer's disease alzheimer's

Neuromuscular Disease Therapeutics Market to Grow by USD 4.46 bn | Technavio
Published: 2022-03-16 (Crawled : 03:00) - prnewswire.com
NVSEF | News | $93.6375 6.88% 82K

| 15.32% | O: 2.25% H: 0.0% C: 0.0%
NVS | News | $93.08 -0.13% 0.86% 1.2M

| 10.19% | O: 0.74% H: 0.0% C: 0.0%
SNY | News | $46.125 0.71% 0.7% 3.7M

| -10.83% | O: 0.82% H: 0.0% C: 0.0%
BCLI | $0.5419 2.81% 2.73% 530K

| -82.89% | O: 3.25% H: 2.52% C: 2.2%
BIIB | $192.13 -1.55% -1.57% 1.3M

| -1.12% | O: 1.96% H: 1.5% C: 1.28%
therapeutics disease

56%

44%

INVO | $1.76 131.58% 56.82% 230M

SINT | $0.0365 59.39% 37.26% 470M

WISA 4 | $9.19 50.66% 33.7% 65M

EDBL | News | $6.73 47.91% 32.39% 13M

GCTK | $0.715 36.27% 26.62% 640K

TCON | $2.33 36.26% 26.61% 2M

TIRX | $0.48 6.43% 24.58% 4.8M

KZIA | $0.38 30.58% 23.42% 300K

VNDA | News | $5.23 29.14% 22.56% 24M

ATNF | $1.91 29.05% 22.51% 310K

Save your searches and get alerts when important news are released.